Stay updated on COMBAT-CRPC: Bipolar Androgen Therapy and Nivolumab Clinical Trial
Sign up to get notified when there's something new on the COMBAT-CRPC: Bipolar Androgen Therapy and Nivolumab Clinical Trial page.

Latest updates to the COMBAT-CRPC: Bipolar Androgen Therapy and Nivolumab Clinical Trial page
- Check5 days agoChange DetectedRevision metadata updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision note, Revision: v3.4.2, has been added. The prior government funding notice and the earlier revision note Revision: v3.4.1 have been removed.SummaryDifference0.4%

- Check41 days agoChange DetectedA government funding lapse notice was added at the top of the page, notifying that information may not be up to date and transactions may be delayed, with links to cc.nih.gov and opm.gov for status updates. The page revision tag updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check48 days agoChange DetectedUI/metadata updates: a glossary toggle is now shown, labels were adjusted (Last Update Submitted that Met QC Criteria; No FEAR Act Data), and the revision tag updated to v3.4.0.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded a dedicated Locations section with site listings for California, Maryland, and Massachusetts, and updated the page revision to v3.3.3. Removed the HHS Vulnerability Disclosure link and the separate state location headers.SummaryDifference0.4%

Stay in the know with updates to COMBAT-CRPC: Bipolar Androgen Therapy and Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the COMBAT-CRPC: Bipolar Androgen Therapy and Nivolumab Clinical Trial page.